Phase I study of S-1, cisplatin, and paclitaxel in patients with advanced gastric cancer(OGSG0703)
研究実績
検索結果:
すべて の研究実績
Phase II study of weekly paclitaxel as third-line chemotherapy for advanced or recurrent gastric cancer(OGSG0602)
Phase II trial of S-1 for elderly patients over 75 years with advanced gastric cancer as first-line treatment(OGSG0404)
Phase III Trail of perioperative alone compared with perioperative plus postoperative antimicrobial prophylaxis in gastric cancer surgery (OGSG0501)
腹膜転移を伴う高度進行・再発胃癌におけるS-1+Paclitaxel併用療法のFeasibility試験(OGSG0401)
A Feasibility Study of UFT/LV and Irinotecan (TEGAFIRI) in Advanced or Metastatic Colorectal Cancer: Osaka Gastrointestinal Cancer Chemotherapy Study Group (OGSG) PROG 0304
Randomized phase II trial of S-1 plus irinotecanversus S-1 plus paclitaxelas first-line treatment for advanced gastric cancer (OGSG0402)
Phase I/II study of weekly taxol plus irinotecan for patients with advanced of recurrent gastric cancer (OGSG0104)
A feasibility/phase II study of UFT/LV and irinotecan (TEGAFIRI) in advanced or metastatic colorectal cancer (CRC) (OGSG 0304)
Preventive effect of Carbamazepine for neurotoxicity of modified FOLFOX6 of metastatic colorectal cancer (mCRC): a prospective phase II study (OGSG 0603 study)